Your browser doesn't support javascript.
loading
Construction and validation of a progression prediction model for locally advanced rectal cancer patients received neoadjuvant chemoradiotherapy followed by total mesorectal excision based on machine learning.
Hu, Jitao; Sheng, Yuanyuan; Ma, Jinlong; Tang, Yujie; Liu, Dong; Zhang, Jianqing; Wei, Xudong; Yang, Yang; Liu, Yueping; Zhang, Yongqiang; Wang, Guiying.
Affiliation
  • Hu J; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Sheng Y; School of Information Science and Engineering, Hebei University of Science and Technology, Shijiazhuang, China.
  • Ma J; School of Information Science and Engineering, Hebei University of Science and Technology, Shijiazhuang, China.
  • Tang Y; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu D; Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang J; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wei X; Department of General Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Yang Y; Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu Y; Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang Y; School of Information Science and Engineering, Hebei University of Science and Technology, Shijiazhuang, China.
  • Wang G; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Front Oncol ; 13: 1231508, 2023.
Article in En | MEDLINE | ID: mdl-38328435
ABSTRACT

Background:

We attempted to develop a progression prediction model for local advanced rectal cancer(LARC) patients who received preoperative neoadjuvant chemoradiotherapy(NCRT) and operative treatment to identify high-risk patients in advance.

Methods:

Data from 272 LARC patients who received NCRT and total mesorectal excision(TME) from 2011 to 2018 at the Fourth Hospital of Hebei Medical University were collected. Data from 161 patients with rectal cancer (each sample with one target variable (progression) and 145 characteristic variables) were included. One Hot Encoding was applied to numerically represent some characteristics. The K-Nearest Neighbor (KNN) filling method was used to determine the missing values, and SmoteTomek comprehensive sampling was used to solve the data imbalance. Eventually, data from 135 patients with 45 characteristic clinical variables were obtained. Random forest, decision tree, support vector machine (SVM), and XGBoost were used to predict whether patients with rectal cancer will exhibit progression. LASSO regression was used to further filter the variables and narrow down the list of variables using a Venn diagram. Eventually, the prediction model was constructed by multivariate logistic regression, and the performance of the model was confirmed in the validation set.

Results:

Eventually, data from 135 patients including 45 clinical characteristic variables were included in the study. Data were randomly divided in an 82 ratio into a data set and a validation set, respectively. Area Under Curve (AUC) values of 0.72 for the decision tree, 0.97 for the random forest, 0.89 for SVM, and 0.94 for XGBoost were obtained from the data set. Similar results were obtained from the validation set. Twenty-three variables were obtained from LASSO regression, and eight variables were obtained by considering the intersection of the variables obtained using the previous four machine learning methods. Furthermore, a multivariate logistic regression model was constructed using the data set; the ROC indicated its good performance. The ROC curve also verified the good predictive performance in the validation set.

Conclusions:

We constructed a logistic regression model with good predictive performance, which allowed us to accurately predict whether patients who received NCRT and TME will exhibit disease progression.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: